NONOF:OTCMKTS
Novo Nordisk A/S
38,48 $
arrow_upward
+0,36%(+0,14) 1 d.
30. sept., 14:43:08 GMT-4 · USD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: NONOF…
Atvērt
38,01 $
Augsta
38,53 $
Zema
37,91 $
Tirgus kapitalizācija
129,09 mljrd.
Vid. apjoms
135,37 tūkst.
Apjoms
10,88 tūkst.
Augstākā 52 ned.
64,75 $
Zemākā 52 ned.
34,00 $
Beta
0,63
Apgrozībā esošās akcijas
3,39 mljrd.
Darbinieku skaits
67 tūkst.
Atvērt
38,01 $
Augsta
38,53 $
Zema
37,91 $
Tirgus kapitalizācija
129,09 mljrd.
Vid. apjoms
135,37 tūkst.
Apjoms
10,88 tūkst.
Augstākā 52 ned.
64,75 $
Zemākā 52 ned.
34,00 $
Beta
0,63
Apgrozībā esošās akcijas
3,39 mljrd.
Darbinieku skaits
67 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Business North Carolina
·
pirms 2 stundām
NC Trend: Novo Nordisk pilots a $150 million treatment plant in the Triangle.
The Motley Fool
·
pirms 4 stundām
Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market?
Barchart.com
·
pirms 5 stundām
If You Love Speculating, You Should Keep a Close Eye on Novo Nordisk Stock
Il Sole 24 ORE
·
pirms 5 stundām
From AstraZeneca to Novo, investment in biotech continues
Profils
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Par “Novo Nordisk A/S”
ĢenerāldirektorsMaziar Mike Doustdar
Darbinieki66,7 tūkst.
Dibināšanas datums1923. gada 21. dec.
Galvenais birojsBagsværd, Galvaspilsētas reģions, Dānija
Sektors-
Tīmekļa vietnenovonordisk.com